The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Large-scale prediction and testing of drug activity on side-effect targets
Open accessAbstract
Discovering the unintended ‘off-targets’ that predict adverse drug reactions is daunting by empirical methods alone. Drugs can act on several protein targets, some of which can be unrelated by conventional molecular metrics, and hundreds of proteins have been implicated in side effects. Here we use a computational strategy to predict the activity of 656 marketed drugs on 73 unintended ‘side-effect’ targets. Approximately half of the predictions were confirmed, either from proprietary databases unknown to the method or by new experimental assays. Affinities for these new off-targets ranged from 1 nM to 30 μM. To explore relevance, we developed an association metric to prioritize those new off-targets that explained side effects better than any known target of a given drug, creating a drug–target–adverse drug reaction network. Among these new associations was the prediction that the abdominal pain side effect of the synthetic oestrogen chlorotrianisene was mediated through its newly discovered inhibition of the enzyme cyclooxygenase-1. The clinical relevance of this inhibition was borne out in whole human blood platelet aggregation assays. This approach may have wide application to de-risking toxicological liabilities in drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
Altschul, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.17.3389 · Cited by 73,302
Extended-Connectivity Fingerprints
Rogers, D., & Hahn, M. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100050t · Cited by 7,524
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,861
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Relating protein pharmacology by ligand chemistry
Keiser, M. J., Roth, B. L., Armbruster, B. N., Ernsberger, P., Irwin, J. J., & Shoichet, B. K. (2007) · Nature Biotechnology · doi:10.1038/nbt1284 · Cited by 2,402
Self-citationA molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
Curran, M. E., Splawski, I., Timothy, K. W., Vincen, G. M., Green, E. D., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90358-5 · Cited by 2,259
Shelley, J. C., Cholleti, A., Frye, L. L., Greenwood, J. R., Timlin, M. R., & Uchimaya, M. (2007) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-007-9133-z · Cited by 2,045
Yıldırım, M. A., Goh, K.-I., Cusick, M. E., Barabási, A.-L., & Vidal, M. (2007) · Nature Biotechnology · doi:10.1038/nbt1338 · Cited by 1,708
Predicting new molecular targets for known drugs
Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667
Self-citationThe Medical Dictionary for Regulatory Activities (MedDRA)
Brown, E. G., Wood, L., & Wood, S. (1999) · Drug Safety · doi:10.2165/00002018-199920020-00002 · Cited by 1,390
Drug target identification using side-effect similarity
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248
A side effect resource to capture phenotypic effects of drugs
Kuhn, M., Campillos, M., Letunic, I., Jensen, L. J., & Bork, P. (2010) · Molecular Systems Biology · doi:10.1038/msb.2009.98 · Cited by 899
Global mapping of pharmacological space
Paolini, G. V., Shapland, R. H. B., van Hoorn, W. P., Mason, J. S., & Hopkins, A. L. (2006) · Nature Biotechnology · doi:10.1038/nbt1228 · Cited by 811
Ongoing and future developments at the Universal Protein Resource
The UniProt Consortium (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1020 · Cited by 729
Rothman, R. B., Baumann, M. H., Savage, J. E., Rauser, L., McBride, A., Hufeisen, S. J., & Roth, B. L. (2000) · Circulation · doi:10.1161/01.cir.102.23.2836 · Cited by 722
Arrowsmith, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3439 · Cited by 622
Phase III and submission failures: 2007–2010
Arrowsmith, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3375 · Cited by 480
Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage
Schoen, R. T., & Vender, R. J. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90344-6 · Cited by 332
Bender, A., Scheiber, J., Glick, M., Davies, J. W., Azzaoui, K., Hamon, J., Urban, L., Whitebread, S., & Jenkins, J. L. (2007) · ChemMedChem · doi:10.1002/cmdc.200700026 · Cited by 327
Self-citationHERG, a Primary Human Ventricular Target of the Nonsedating Antihistamine Terfenadine
Roy, M.-L., Dumaine, R., & Brown, A. M. (1996) · Circulation · doi:10.1161/01.cir.94.4.817 · Cited by 303
Giacomini, K. M., Krauss, R. M., Roden, D. M., Eichelbaum, M., Hayden, M. R., & Nakamura, Y. (2007) · Nature · doi:10.1038/446975a · Cited by 276
Protein binding specificity versus promiscuity
Schreiber, G., & Keating, A. E. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2010.10.002 · Cited by 268
Data completeness—the Achilles heel of drug-target networks
Mestres, J., Gregori-Puigjané, E., Valverde, S., & Solé, R. V. (2008) · Nature Biotechnology · doi:10.1038/nbt0908-983 · Cited by 265
Mestres, J., Gregori-Puigjané, E., Valverde, S., & Solé, R. V. (2009) · Molecular BioSystems · doi:10.1039/b905821b · Cited by 203
Tatonetti, N. P., Denny, J. C., Murphy, S. N., Fernald, G. H., Krishnan, G., Castro, V, Yue, P., Tsau, P. S., Kohane, I., Roden, D. M., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.83 · Cited by 201
Modeling Promiscuity Based on in vitro Safety Pharmacology Profiling Data
Azzaoui, K., Hamon, J., Faller, B., Whitebread, S., Jacoby, E., Bender, A., Jenkins, J. L., & Urban, L. (2007) · ChemMedChem · doi:10.1002/cmdc.200700036 · Cited by 176
Self-citationSelective COX-1 Inhibition: A Therapeutic Target to be Reconsidered
G. Perrone, M., Scilimati, A., Simone, L., & Vitale, P. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710793205408 · Cited by 175
Quantifying the Relationships among Drug Classes
Hert, J., Keiser, M. J., Irwin, J. J., Oprea, T. I., & Shoichet, B. K. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci8000259 · Cited by 169
Self-citationMapping Adverse Drug Reactions in Chemical Space
Scheiber, J., Jenkins, J. L., Sukuru, S. C. K., Bender, A., Mikhailov, D., Milik, M., Azzaoui, K., Whitebread, S., Hamon, J., Urban, L., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801546k · Cited by 160
Self-citationApplication of Belief Theory to Similarity Data Fusion for Use in Analog Searching and Lead Hopping
Muchmore, S. W., Debe, D. A., Metz, J. T., Brown, S. P., Martin, Y. C., & Hajduk, P. J. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci7004498 · Cited by 160
Peters, J., Schnider, P., Mattei, P., & Kansy, M. (2009) · ChemMedChem · doi:10.1002/cmdc.200800411 · Cited by 156
Chemical informatics and target identification in a zebrafish phenotypic screen
Laggner, C., Kokel, D., Setola, V., Tolia, A., Lin, H., Irwin, J. J., Keiser, M. J., Cheung, C. Y. J., Minor, D. L., Roth, B. L., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.732 · Cited by 126
Self-citationOprea, T. I., Nielsen, S. K., Ursu, O., Yang, J. J., Taboureau, O., Mathias, S. L., Kouskoumvekaki, I. A., Sklar, L. A., & Bologa, C. (2011) · Molecular Informatics · doi:10.1002/minf.201100023 · Cited by 123
Cardiovascular hazard and non-steroidal anti-inflammatory drugs
Wong, D., Wang, M., Cheng, Y., & FitzGerald, G. A. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.02.001 · Cited by 102
Kuo, C., Huang, R.-C., & Lou, B. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26451-8 · Cited by 88
An Open Standard for Chemical Structure Representation: The IUPAC Chemical Identifier
Stein, S. E., Heller, S. R., & Tchekhovskoi, D. V. (2003) · Cited by 71
Lee, S., Lee, K. H., Song, M., & Lee, D. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-s2-s2 · Cited by 68
Yang, L., Luo, H., Chen, J., Xing, Q., & He, L. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp312 · Cited by 67
Drug Adverse Reaction Target Database (DART)
Ji, Z. L., Han, L., Yap, C. W., Sun, L., Chen, X., & Chen, Y. (2003) · Drug Safety · doi:10.2165/00002018-200326100-00002 · Cited by 64
Cytokine-associated drug toxicity in human hepatocytes is associated signaling network dysregulation
Hendriks, B. S., Cosgrove, B. D., Alexopoulos, L. G., Hang, T.-C., Sorger, P. K., Griffith, L. G., & Lauffenburger, D. A. (2009) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 59
Protein Adducts As Prospective Biomarkers of Nevirapine Toxicity
Antunes, A. M. M., Godinho, A. L. A., Martins, I. L., Oliveira, M. C., Gomes, R. A., Coelho, A. V., Beland, F. A., & Marques, M. M. (2010) · Chemical Research in Toxicology · doi:10.1021/tx100186t · Cited by 49
Matthews, E. J., & Frid, A. A. (2009) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2009.11.006 · Cited by 37
Akarasereenont, P., Tripatara, P., Chotewuttakorn, S., Palo, T., & Thaworn, A. (2006) · Platelets · doi:10.1080/09537100600745302 · Cited by 37
Kinase inhibition-related adverse events predicted from in vitro kinome and clinical trial data
Yang, X. H., Huang, Y., Crowson, M. G., Li, J., Maitland, M. L., & Lussier, Y. A. (2010) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2010.04.006 · Cited by 36
DITOP: drug-induced toxicity related protein database
Zhang, J., Huang, W., Zeng, J., Huang, W.-H., Wang, Y., Zhao, R., Han, B., Liu, Q., Chen, Y., & Ji, Z. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm139 · Cited by 36
The Use of Computer Models in Pharmaceutical Safety Evaluation
Boyer, S. K. (2009) · Alternatives to Laboratory Animals · doi:10.1177/026119290903700505 · Cited by 20
Cited by
ProTox-II: a webserver for the prediction of toxicity of chemicals
Banerjee, P., Eckert, A. O., Schrey, A. K., & Preissner, R. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky318 · Cited by 3,195
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
QSAR Modeling: Where have you been? Where are you going to?
Cherkasov, A., Muratov, E. N., Fourches, D., Varnek, A., Baskin, I. I., Cronin, M., Dearden, J., Gramatica, P., Martin, Y. C., Todeschini, R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4004285 · Cited by 2,164
Computational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
SwissTargetPrediction: a web server for target prediction of bioactive small molecules
Gfeller, D., Grosdidier, A., Wirth, M., Daina, A., Michielin, O., & Zoete, V. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku293 · Cited by 1,791
Metadata
- Authors
- Lounkine, E., Keiser, M. J., Whitebread, S., Mikhailov, D., Hamon, J., Jenkins, J. L., Lavan, P., Weber, E., Doak, A. K., Côté, S., Shoichet, B. K., & Urban, L.
- Venue
- Nature
- Published
- 2012-06
- Volume
- 486
- Issue
- 7403
- Pages
- 361-367
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2070789802
- Cited by
- 881
- References
- 49
- FWCI
- 102.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.